EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calcium isotope composition in serum and urine for the assessment of bone mineral balance (BMB) – The Osteolabs post-market follow-up study

A Eisenhauer, A Hastuti, A Heuser, A Kolevica, B Brandt, R Shroff, J Oehme, M Müller

Bone · 2024

DOI: 10.1016/j.bone.2024.117210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2024. Verfasst von A Eisenhauer und 7 weiteren Autor:innen. Beteiligte Einrichtung: GEOMAR, Helmholtz-Center for Ocean Research Kiel, Germany. Electronic address: aeisenhauer@geomar.de. Hauptthemen laut MEDLINE: Bone Density, Calcium Isotopes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To further explore the clinical applicability of the calcium (Ca) isotope marker (CIM), we determined the 44Ca/42Ca isotope ratio in blood serum and urine. This ratio is expressed in the conventional δ-notation (as defined in the text below) specifically as CIM-serum for serum and as CIM-urine for urine. Our study tested the hypothesis that CIM values can differentiate between positive and negative bone mineral balance (BMB) across a diverse clinical population considering variables such as age, gender, and diet. The threshold values (CIM-serum: -0.85 ± 0.06 ‰ and CIM-urine: 0.23 ± 0.06 ‰) established in the OsteoGeo study (NCT02967978, Eisenhauer et al., 2019) were evaluated in 2320 participants as part of a surveillance study referred to as Osteolabs study. The earlier study revealed women with osteoporosis had an average CIM-serum value of -0.91 ± 0.21 ‰ (N = 24) and a CIM-urine value of 0.18 ± 0.33 ‰ (N = 71) that are significantly below the threshold values (p = 0.02 for urine, one-sided Wilcoxon rank test, p < 0.001 for serum, one-sided Student's t-test). Diseases affecting BMB such as osteoporosis, acute and chronic kidney disease (CKD), hyperthyroidism, breast cancer, prostate cancer, and myeloma were associated with significantly lower average CIM values, falling below the equilibrium thresholds and indicating negative BMB. In contrast, patients receiving osteoprotective treatments such as denosumab, Romosozumab, bisphosphonates, or hormone replacement therapy for certain diseases, had CIM values above the equilibrium thresholds indicating a positive BMB. Additionally, Ca supplements taken by some of the patients ((N = 22 (serum), N = 49 (urine), median dose: 500 mg) showed a Ca isotope composition approximately 1 ‰ higher than that from a normal diet. Consequently, their CIM values need to be adjusted to account for the amount and duration of supplementation to be comparable to those with a normal diet. Participants taking vitamin D (237 women; 58 men) showed no significant difference from the average values of the study group. Counterintuitively, the possible impact of malnutrition on individual BMB was most pronounced in vegans, who exhibited the highest average CIM-urine values compared to patients on a normal diet (p < 0.001, N = 17). The results of this study were consistent with the registered OsteoGeo study (NCT02967978) and other earlier published Ca isotope-based studies on BMB. We confirm that the CIM threshold values determined in the OsteoGeo study are generally valid for this much larger and diverse surveillance study group covering a diverse population encompassing various medical conditions and therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone DensityCalcium IsotopesAdultAgedFemaleHumansMaleMiddle AgedCalciumFollow-Up StudiesClinical Trials as Topic

Stichwörter der Autor:innen

Bone biomarkerBone ca balanceCa isotopesMass-spectrometryOsteoporosis

Substanzen

CalciumCalcium Isotopes

Autor:innen und Institutionen

  • GEOMAR, Helmholtz-Center for Ocean Research Kiel, Germany. Electronic address: aeisenhauer@geomar.de.
  • GEOMAR, Helmholtz-Center for Ocean Research Kiel, Germany; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  • GEOMAR, Helmholtz-Center for Ocean Research Kiel, Germany.
  • University Hospital Schleswig-Holstein, Kiel, Germany.
  • UCL Great Ormond Street Hospital, London, United Kingdom.
  • Osteolabs GmbH, Kiel, Germany.

Zitieren

APA

Eisenhauer, A., Hastuti, A., Heuser, A., Kolevica, A., Brandt, B., Shroff, R., Oehme, J., & Müller, M. (2024). Calcium isotope composition in serum and urine for the assessment of bone mineral balance (BMB) – The Osteolabs post-market follow-up study. Bone. https://doi.org/10.1016/j.bone.2024.117210

Vancouver

Eisenhauer A, Hastuti A, Heuser A, Kolevica A, Brandt B, Shroff R, et al. Calcium isotope composition in serum and urine for the assessment of bone mineral balance (BMB) – The Osteolabs post-market follow-up study. Bone. 2024. doi:10.1016/j.bone.2024.117210

BibTeX
@article{Eisenhauer2024,
  author = {Eisenhauer, A and Hastuti, A and Heuser, A and Kolevica, A and Brandt, B and Shroff, R and Oehme, J and Müller, M},
  title = {Calcium isotope composition in serum and urine for the assessment of bone mineral balance (BMB) – The Osteolabs post-market follow-up study},
  journal = {Bone},
  year = {2024},
  doi = {10.1016/j.bone.2024.117210}
}
Kostenlos starten →